Document text
Principal Investigator: Guowei Wei
Organization: MICHIGAN STATE UNIVERSITY
Fiscal Year: 2020
Award: $116,389
Funding agency: National Institute of General Medical Sciences
Project Summary
The success of the ongoing battle with coronavirus disease 2019 (COVID-19) caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) depends crucially on the availability of
effective diagnostics, vaccines, antibody therapeutics, and small-molecular drugs. Although
SARS-CoV-2 mutates slower than the viruses that cause the flu and the common cold, it has had
more than 8300 observed single mutations on its genome of 29,900 nucleotides by June 1, 2020.
We show that these mutations might have devastating effects on COVID-19 diagnostics,
vaccines, antibody therapeutics, and small-molecular drugs (J. Chem. Inf. Model. In press). We
will develop new artificial intelligence (AI) to forecast SARS-CoV-2 future mutations. Leveraging
on state-of-art methods developed under the present R01 award, we will design mutation-
resistant vaccines, antibody therapeutics, and small-molecular drugs. The CPUs and GPUs
requested in this supplement will be essential for my lab to continue the research of the present
R01 award and to apply the methods developed in this award to attack fundamental problems in
combating COVID-19.
Terms: <2019 novel coronavirus><2019-nCoV><AI system><Acute Nasopharyngitis><Address><Adopted><Affinity><Angiotensin Converting Enzyme><Angiotensin I-Converting Enzyme><Antibodies><Antibody Affinity><Artificial Intelligence><Attention><Award><Binding><Binding Proteins><CD143 Antigens><COVID-19><COVID-19 vaccine><COVID19><COVID19 vaccine><Carboxycathepsin><Cell Body><Cells><Common Cold><Computer Reasoning><Conflict><Conflict (Psychology)><Coronaviridae><Coronavirus><Crystallization><Development><Diagnostic><Diagnostic Reagent><Diagnostic tests><Dipeptidyl Peptidase A><Drug resistance><Drug usage><Drugs><Evolution><Failure><Future><Gene Transcription><Genetic Alteration><Genetic Change><Genetic Transcription><Genetic defect><Genome><Goals><Grant><Heterogeneity><Induced DNA Alteration><Induced Mutation><Induced Sequence Alteration><Influenza A><Influenza A virus><Influenza Viruses Type A><Influenzavirus A><Kininase A><Kininase II><Ligand Binding Protein><Ligand Binding Protein Gene><Machine Intelligence><Machine Learning><Manuscripts><Math><Mathematics><Medication><Medicine><Methods><Mission><Modeling><Modification><Molecular><Molecular Interaction><Mutate><Mutation><NIGMS><National Institute of General Medical Sciences><Nucleotides><Orthomyxovirus Type A><Peptidyl-Dipeptidase A><Pharmaceutic Preparations><Pharmaceutical Preparations><Phase><Preventative measure><Preventative vaccine><Preventive measure><Preventive vaccine><Process><Prophylactic vaccine><Protein Binding><Proteins><RNA Expression><RNA Viruses><Receptor Protein><Recurrence><Recurrent><Reporting><Research><Rhinovirus><SARS><SARS Virus><SARS corona virus><SARS coronavirus><SARS coronavirus disease><SARS-Associated Coronavirus><SARS-CoV><SARS-CoV disease><SARS-CoV-2><SARS-CoV2><SARS-Related Coronavirus><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related coronavirus 2><Severe Acute Respiratory Syndrome><Severe Acute Respiratory Syndrome CoV disease><Severe Acute Respiratory Syndrome Virus><Severe Acute Respiratory Syndrome corona virus><Severe Acute Respiratory Syndrome coronavirus><Severe Acute Respiratory Syndrome coronavirus disease><Severe acute respiratory syndrome coronavirus 2><Site><Structure><Therapeutic><Therapeutic antibodies><Time><Transcription><Type A Influenza><Vaccines><Viral><Virulence><Virus><Work><Wuhan coronavirus><antigen antibody affinity><antigen antibody binding><autoencoder><autoencoding neural network><base><bound protein><combat><corona virus><corona virus disease 2019><corona virus disease 2019 vaccine><coronavirus disease 2019><coronavirus disease 2019 vaccine><design><designing><develop a vaccine><development of a vaccine><developmental><drug resistant><drug use><drug/agent><experience><flu><genome mutation><improved><inhibitor><inhibitor/antagonist><machine learned><news><pandemic><pandemic disease><protein folding><receptor><receptor binding><receptor bound><reconstruction><resistance mutation><resistance to Drug><resistant mutation><resistant to Drug><severe acute respiratory syndrome-CoV><success><vaccine development><vaccine formulation>